Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26723
Abstract: We analyzed a Japanese registry database to elucidate the incidence, risk factors, and outcomes of adenovirus (AdV) disease after autologous and allogeneic hematopoietic cell transplantation (HCT) in contemporary real‐world patients. We evaluated the cumulative incidence… read more here.
Keywords: adv disease; cell; disease; hct ... See more keywords
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3454-y
Abstract: Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal prognosis and further therapeutic options are limited. One potential curative… read more here.
Keywords: second allogeneic; relapsed acute; hct; survival ... See more keywords
T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Hematology"
DOI: 10.1007/s12185-020-02890-1
Abstract: Posttransplant lymphoproliferative disorder (PTLD) after allogeneic hematopoietic cell transplantation (HCT) is usually donor derived, associated with Epstein–Barr virus (EBV), and of B-cell origin. T-cell PTLD (T-PTLD) after allogeneic HCT is extremely rare. Four of 1015… read more here.
Keywords: posttransplant lymphoproliferative; ptld allogeneic; ptld; cell ... See more keywords
Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study
Sign Up to like & getrecommendations! Published in 2018 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-018-0282-6
Abstract: Recipients of allogeneic hematopoietic cell transplantation (HCT) are now surviving longer due to impressive reductions in early transplant-related mortality [1]. Delayed transplant-related mortality in long-term allogeneic HCT survivors now exceeds relapse-related mortality [2, 3]. For… read more here.
Keywords: risk; risk factors; disease; coronary artery ... See more keywords
Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT
Sign Up to like & getrecommendations! Published in 2024 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-024-02459-0
Abstract: We looked at treatment rates and center density across countries for patients treated in 2022; 46,143 HCTs (19,011 (41.2%) allogeneic, 27,132 (58.8%) autologous) reported by 689 centers. 4329 patients received advanced cellular therapies, 3205 were… read more here.
Keywords: utilization hematopoietic; use; allogeneic hct; hct ... See more keywords
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT
Sign Up to like & getrecommendations! Published in 2025 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-025-02524-2
Abstract: In 2023, 47,731 HCT (20,485 (42.9%) allogeneic and 27,246 (57.1%) autologous) in 43,902 patients were reported by 696 European centers. 6042 patients received advanced cellular therapies, 4888 of which were CAR-T. Compared to the previous… read more here.
Keywords: cellular therapies; use; autologous hct; allogeneic hct ... See more keywords
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Hematology"
DOI: 10.1097/moh.0000000000000743
Abstract: Purpose of review Several studies showed that age alone should not be used as an arbitrary parameter to exclude patients from allogeneic hematopoietic cell transplantation (HCT). The accessibility to allogeneic HCT programs for older patients… read more here.
Keywords: allogeneic hematopoietic; older patients; hct; age ... See more keywords
Gut microbiome in allogeneic HCT survivors: The insults are gone but the damage lingers
Sign Up to like & getrecommendations! Published in 2023 at "British Journal of Haematology"
DOI: 10.1111/bjh.18653
Abstract: The gut microbiome is an important regulator of health and disease. The report by Hino et al. suggests that damage to the microbiome, inflicted before and soon after allogeneic haematopoietic progenitor cell transplantation, does not… read more here.
Keywords: damage; microbiome allogeneic; gut microbiome; hct survivors ... See more keywords
Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Transplantation"
DOI: 10.1111/petr.13210
Abstract: Relapsed ALK‐positive ALCL often is responsive to CRZ monotherapy. The subsequent role of allogeneic HCT after achieving second remission is poorly understood. We report 6 children who underwent allogeneic HCT for relapsed ALCL after CRZ.… read more here.
Keywords: allogeneic hematopoietic; one patient; transplant; monotherapy ... See more keywords
Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220970608
Abstract: Introduction Continuous infusion (CIVI) cyclosporine (CsA) is an alternative for allograft recipients intolerant of twice daily infusions (TDI). The importance of achieving therapeutic levels of CsA early after allogeneic HCT has been demonstrated in previous… read more here.
Keywords: cyclosporine; infusion; allogeneic hct; overall survival ... See more keywords
Critical Care Support in Infants Post-Allogeneic HCT: Large Single-Center Cohort Experience
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-212041
Abstract: Introduction Allogeneic hematopoietic cell transplantation (HCT) is a potentially life-saving treatment for various diseases observed in childhood but may be associated with significant transplant-related morbidity/mortality. Approximately 10% of pediatric patients undergoing HCT may require critical… read more here.
Keywords: care support; allogeneic hct; post; hct ... See more keywords